Search

everythinglearnresearchcommunity

for

Search:↓

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

MVP treatment is effective and safe for recurrent breast cancer.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

The patient showed tumor stability and improved health using a new Periwinkle preparation with chemotherapy.

Patients prefer the higher 50 mg dose of ritlecitinib for better hair regrowth despite higher risks.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

Cyproterone acetate is used for topical treatment of diseases dependent on male hormones.

Vismodegib can cause muscle spasms, taste changes, hair loss, fatigue, weight loss, and possibly new issues like skin cancer, dehydration, and swallowing problems, needing close monitoring.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

A new 3D breast tumor model helps test drug effects more accurately than traditional methods.

Tofacitinib may help treat hair loss in children with alopecia areata.

A 65-year-old man developed a serious skin cancer linked to a drug he was taking for a fungal infection after a bone marrow transplant.

BLZ-100 is safe for use in skin cancer surgery and may help identify cancerous tissue.

Personalized sonidegib dosing can effectively treat Gorlin-Goltz syndrome with fewer side effects.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.

Cancer treatments often cause hair loss, and more research is needed to prevent and treat it.

Tofacitinib helped regrow hair in a woman with alopecia areata.

Combining Western chemotherapy with Traditional Chinese Medicine can reduce side effects and improve immune response in treating bone and soft tissue tumors.

JAK/STAT1 pathway causes hair loss during chemotherapy by reducing Shh in hair follicles.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Semecarpus anacardium leaf extracts may offer safe, effective cancer treatment alternatives.

Patients with advanced breast cancer prioritize quality of life, overall survival, and progression-free survival in treatment decisions.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Chrysin makes docetaxel more effective and reduces its side effects in lung cancer treatment.

The new cocrystal KET-PABA is a more effective and safe anti-inflammatory treatment for skin conditions in mice.

Cepharanthine shows promise as a COVID-19 treatment.